Chang, Woohyok
Kim, Jinhee
Jeon, Junsik
Park, Soyeon
Funding for this research was provided by:
Roche
Article History
Received: 2 April 2026
Accepted: 8 June 2026
First Online: 11 June 2026
Declarations
:
: This study adhered to the tenets of the Declaration of Helsinki. The study was reviewed by the Public Institutional Review Board (Public IRB) designated by the Ministry of Health and Welfare of South Korea and operated by the Korea National Institute for Bioethics Policy (approval number: P01-202510-01-057; date: 20 January 2026), which granted an exemption from full ethical review in accordance with Article 13 of the Enforcement Rules of the Bioethics and Safety Act of South Korea, given the retrospective nature of the study using de-identified medical records. The need for informed consent was waived by the same committee for the same reason.
: Not applicable.
: WC is a consultant for Bayer and Roche. This study was financially supported by Roche. The sponsor had no role in the design, conduct, analysis, interpretation of data, or reporting of this study. JK, JJ, and SP declare no competing interests.